Researchers assess the airway microbiome and host immune-inflammatory responses to identify treatable aspects of severe ...

Dupilumab decreases general and type 2 inflammatory biomarker levels in children with moderate to severe atopic dermatitis.

The FDA approved benralizumab (Fasenra) for adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).

Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission compared to placebo, consistent with improvements seen in ...

Depemokimab was shown to reduce exacerbations in patients with severe asthma. The proportions of adverse events of ...

A non-fasting glucose test measures the amount of glucose (sugar) in your blood after eating. Normal non-fasting glucose levels are below 140 milligrams per deciliter of blood (mg/dL). If they're ...

Corticosteroids cause profound eosinophilia, manifested by a decrease in the eosinophil count to < 25 cells/mm 3. Corticosteroid-induced eosinophilia is also caused by the redistribution phenomenon.

The use of Siddha drug treatment can help reduce anemia among adolescent girls as per a study that highlights the potential ...

Its purpose is to ensure blood stays in arteries and veins, and helps carry hormones, vitamins, and enzymes throughout the body. Normal albumin levels are between 3.4 to 5.4 grams per deciliter (g/dL) ...

Sangeetha Venugopal, MD, MS, discussed the evolving landscape of acute myeloid leukemia treatment as well as unmet needs ...

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology to optimize drug delivery for applications with significant unmet need, ...